Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism SIK2 inhibitors(Serine/threonine-protein kinase SIK2 inhibitors), SIK3 inhibitors(SIK family kinase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H20N6O2 |
InChIKeyOYDTWNVVTPPDDO-UHFFFAOYSA-N |
CAS Registry2810810-00-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | FR | 29 Mar 2024 | |
Inflammation | Preclinical | FR | 29 Mar 2024 |